|1|Cosmesis Outcomes for Sector Resection for Ductal Carcinoma In Situ (DCIS). (24380921)
Fosh B.... Eaton M.
|2|MarginProbe(Ar) - Final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ. (24291375)
Thill M.... Blohmer J.U.
|3|US appearance of ductal carcinoma in situ. (23322838)
Wang L.C.... Mendelson E.B.
|4|A review of the management of ductal carcinoma in situ following breast conserving surgery. (24070852)
Boxer M.M.... Chua B.H.
|5|Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. (24025166)
Casbas-Hernandez P.... Troester M.A.
|6|Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. (23624751)
Collins L.C.... Habel L.A.
|7|Molecular subtypes of ductal carcinoma in situ in African American and Caucasian American women: distribution and correlation with pathological features and outcome. (23639792)
Sharaf Aldeen B.... Nassar Warzecha H.
|8|Extensive pure ductal carcinoma in situ of the breast: Identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery. (24388733)
Guillot E.... Reyal F.
|9|Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ. (23971464)
Bae M.S.... Han W.
|10|Ductal carcinoma in situ: an overview. (23984897)
Duggal S.... Julian T.B.
|11|Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: Interdisciplinary approaches. (24225267)
Sherman M.E.... Gierach G.L.
|12|Ductal carcinoma in situ: a rose by any other name. (24068770)
Wickerham D.L.... Julian T.B.
|13|Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. (23477556)
Kaur H.... Mattingly R.R.
|14|Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship. (23539741)
Thike A.A.... Tan P.H.
|15|Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens. (23199579)
Provenzano E.... Pinder S.E.
|16|MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. (23399321)
Li S.... Qi L.
|17|Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? (22749764)
Ansari B.... Morton M.J.
|18|Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. (22253459)
Yi M.... Hunt K.K.
|19|The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. (22205445)
Goto M.... Yamada K.
|20|Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast. (22804792)
Hollingsworth A.B.... Stough R.G.
|21|Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy. (22422382)
Suh Y.J.... Yoon J.H.
|22|Validation of a nomogram for predicting risk of local recurrence for ductal carcinoma in situ. (22826276)
Van Zee K.J.... Patil S.
|23|Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. (22392043)
Kuerer H.M.... Hunt K.K.
|24|Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. (21885281)
Thill M.... Dittmer C.
|25|Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive inA situ ductal carcinoma (IDCA +A DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade. (20143189)
Papantoniou V.... Antsaklis A.
|26|The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ. (21943463)
Hayward L.... Cutress R.I.
|27|Synchronous benign-appearing calcifications in patients with ductal carcinoma in situ may not be benign. (20602184)
Tabrizian P.... Menes T.S.
|28|Her-2 positive ductal carcinoma in situ is an independent predictor of tumor recurrence. (21805692)
Shand J.A.... Howe A.
|29|Accelerated partial breast irradiation for pure ductal carcinoma in situ. (20800374)
Park S.S.... Vicini F.A.
|30|Outcomes of screening-detected ductal carcinoma in situ treated with wide excision alone. (21630124)
Fong J.... Mann G.B.
|31|Ductal carcinoma in situ: terminology, classification, and natural history. (20956817)
|32|The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ. (20102367)
Song H.M.... Losken A.
|33|Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study. (19915523)
Castellano I.... Sapino A.
|34|Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy. (21029943)
Chan M.Y.... Lim S.
|35|Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events. (20127359)
GonzA!lez L.O.... Vizoso F.
|36|Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case. (19886717)
|37|Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. (17522367)
Steinman S.... Tang P.
|38|The receptor expression pattern in ductal carcinoma in situ predicts recurrence. (16769278)
Kepple J.... Korourian S.
|39|Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. (17060931)
Wilson G.R.... Bundred N.J.
|40|Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? (15832086)
Tan P.H.... Tse G.M.
|41|Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. (15728167)
Claus E.B.... Carter D.
|42|An in situ carcinoma of the pancreas forming 2 invasive ductal carcinomas. (16025010)
Sanada Y.... Nishimura R.
|43|Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation. (15528970)
Thomassen M.... Gerdes A.M.
|44|Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence. (14612904)
JirstrAPm K.... Landberg G.
|45|Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast. (12713620)
Baqai T.... Shousha S.
|46|Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast. (14645350)
Teo N.B.... Holcombe C.
|47|Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. (11381366)
Leal C.... Page D.L.
|48|Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. (10398079)
Vos C.B.... van de Vijver M.J.
|49|Microsatellite instability in ductal carcinoma in situ of the breast. (9713355)
Walsh T.... Walker R.A.
|50|Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast. (9306962)
Engels K.... Harris A.L.